Bristol-Myers Squibb Company (BMY) 75.57 $BMY Celldex

New Post Public Reply Private Reply Replies (0) Message Board

Aug 4, 2016 at 3:11 PM

Bristol-Myers Squibb Company (BMY) 75.57 $BMY

Celldex (CLDX): What's Ahead for the Stock in Q2 Earnings?
Arpita Dutt - Zacks Investment Research - Thu Aug 04, 8:07AM CDT
With no approved product in its portfolio, investors will remain focused on pipeline related updates from Celldex (CLDX).
CLDX: 4.58 (-0.08), INCY: 90.41 (-0.40), BMY: 75.57 (+0.77), IONS: 37.10 (-0.63)

Bristol-Myers Squibb Announces Dividend
BusinessWire - Wed Aug 03, 3:16PM CDT
The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of thirty-eight cents ($0.38) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on November 1, 2016, to stockholders of record at the close of business on October 7, 2016.
BMY: 75.57 (+0.77)

Pharma ETFs Soaring on Solid Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 11:22AM CDT
Pharma ETFs are in focus in the days ahead on impressive Q2 results.
IHE: 156.77 (+0.25), BIIB: 315.36 (-5.98), JNJ: 123.87 (-0.03), PPH: 62.06 (+0.10), PJP: 68.51 (-0.05), MRK: 57.96 (+0.31), PFE: 35.27 (-0.02), XPH: 47.05 (+0.37), LLY: 82.50 (-0.22), BMY: 75.57 (+0.77)

Pfizer (PFE) Tops on Q2 Earnings, Revenues, Maintains View
Arpita Dutt - Zacks Investment Research - Tue Aug 02, 8:08AM CDT
Pfizer (PFE) surpassed earnings and revenue estimates again in the second quarter.
JNJ: 123.87 (-0.03), PFE: 35.27 (-0.02), LLY: 82.50 (-0.22), BMY: 75.57 (+0.77)

Watch for Shares of Bristol-Myers Squibb (BMY) to Approach Resistance at $75.67
Comtex SmarTrend(R) - Mon Aug 01, 9:23AM CDT
Bristol-Myers Squibb (NYSE:BMY) has opened bullishly above the pivot of $74.73 today and has reached the first level of resistance at $75.24. Investors may be interested in a cross of the next upside pivot targets of $75.67 and $76.61.
BMY: 75.57 (+0.77)

AbbVie (ABBV) Beats on 2Q Earnings, Revenues, Ups View
Arpita Dutt - Zacks Investment Research - Fri Jul 29, 9:44AM CDT
AbbVie (ABBV) raised its 2016 outlook following its Q2 earnings and revenue beat.
JNJ: 123.87 (-0.03), ABBV: 66.35 (-0.22), LLY: 82.50 (-0.22), BMY: 75.57 (+0.77)

Merck (MRK) Updates Outlook Following Q2 Earnings Beat
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:14AM CDT
Merck (MRK) surpassed Q2 earnings expectations by a penny while revenues were in-line with estimates.
JNJ: 123.87 (-0.03), MRK: 57.96 (+0.31), LLY: 82.50 (-0.22), BMY: 75.57 (+0.77)

Neon Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Cancer Vaccine NEO-PV-01
BusinessWire - Fri Jul 29, 7:30AM CDT
Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for its lead program, NEO-PV-01. NEO-PV-01 is a personalized vaccine designed specifically for each patient based on the neoantigen mutations unique to that patient's tumor DNA.
BMY: 75.57 (+0.77)

Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:43AM CDT
Bristol-Myers' (BMY) delivered better-than-expected second-quarter 2016 earnings and revenues; it raised the 2016 earnings outlook yet again.
INVA: 12.86 (-0.15), ANIP: 66.17 (+4.07), PFE: 35.27 (-0.02), BMY: 75.57 (+0.77)

Bristol-Myers Squibb (BMY) Breaks Through Support at $75.39
Comtex SmarTrend(R) - Thu Jul 28, 9:11AM CDT
Bristol-Myers Squibb (NYSE:BMY) has opened bearishly below the pivot of $76.09 today and has reached the first level of support at $75.39. Should the shares continue to fall, the support pivots of $74.30 and $72.51 will be of interest.
BMY: 75.57 (+0.77)

McKesson (MCK) Beats on Q1 Earnings, Maintains Guidance
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:11AM CDT
McKesson Corporation (MCK) reported first-quarter fiscal 2017 (ended Jun 30, 2016) earnings of $3.50 per share, above the Zacks Consensus Estimate of $3.35.
ABC: 88.78 (-1.11), JNJ: 123.87 (-0.03), MCK: 194.70 (-0.44), BMY: 75.57 (+0.77)

Bristol-Myers (BMY) Tops Q2 Earnings and Revenues
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:22AM CDT
Bristol-Myers beat on second-quarter 2016 earnings and revenue estimates.
BMY: 75.57 (+0.77)

Bristol-Myers Squibb Reports Second Quarter Financial Results
BusinessWire - Thu Jul 28, 5:59AM CDT
--Posts Second Quarter GAAP and Non-GAAP EPS of $0.69
BMY: 75.57 (+0.77)

Nivalis (NVLS): Can the Stock Surprise This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:46PM CDT
Nivalis Therapeutics (NVLS), which is expected to report second-quarter 2016 results on Aug 1, posted a negative surprise of 15.91% last quarter.
VRTX: 100.70 (+0.26), NVLS: 5.01 (+0.18), UTHR: 126.09 (+1.23), BMY: 75.57 (+0.77)

CVS Health (CVS) Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:43PM CDT
CVS Health Corporation (CVS) is scheduled to report its second-quarter 2016 results before the opening bell on Aug 2.
ZBH: 130.96 (+0.53), CVS: 96.67 (-0.76), BMY: 75.57 (+0.77), HOLX: 38.69 (-0.31)

Look for Shares of Bristol-Myers Squibb to Potentially Pullback after Yesterday's 1.13% Rise
Comtex SmarTrend(R) - Wed Jul 27, 1:49PM CDT
Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $75.01 to a high of $76.00. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $75.98 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BMY: 75.57 (+0.77)

Bristol-Myers Squibb Rises 1.13% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jul 27, 1:47PM CDT
Bristol-Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $75.01 to a high of $76.00. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $75.98 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BMY: 75.57 (+0.77)

AmerisourceBergen (ABC) Q3 Earnings: Stock to Surprise?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 11:10AM CDT
AmerisourceBergen Corporation (ABC) is set to report third-quarter fiscal 2016 results on Aug 2, before the opening bell.
ABC: 88.78 (-1.11), WBA: 79.93 (+0.33), IRWD: 14.16 (-0.08), BMY: 75.57 (+0.77)

Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:31AM CDT
Hologic (HOLX) has a Zacks Rank #2 (Buy) which along with a 0.00 % ESP makes surprise prediction difficult.
AGN: 253.94 (+1.41), LH: 139.75 (-0.38), BMY: 75.57 (+0.77), HOLX: 38.69 (-0.31)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Concrete Pipe: Foundation of Modern Infrastructure

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Neutonic Sets Sights on U.S. with Walmart Expansion

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

Nukleus Launches Unified Platform for Athletes' Business

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...

Li-Fire Expands Fire Safety Amid Rising Battery Risks

A Crunchy Look at New Fire Safety Moves Well, folks, here's a twist we didn't see coming but sure makes sense in today's electrifying business landscape. Li-Fire, the big brains behind lithium battery fire suppression, is spreading its wings nationwide, or at least its wholesale and distribution programs are. And right ahead of National Fire Safety Week no less—talk...

Managed Connectivity: Key to Modern Multifamily Living

Connectivity Runs the Modern Show Imagine moving into a shiny new apartment, where the biggest hassle isn't unpacking boxes but ensuring your gadgets get online smoothly. That's the reality of today's multifamily living, where the internet is more than a utility—it's the backbone of modern life. And if you think it's just about offering internet access, you're missing...

Ultrabench Revolutionizes AI Model Comparison Game

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Fiber Giants Unite to Boost Connectivity in Montana

Montana's Broadband Transformation Takes a Leap Folks in Northwest Montana, take note. Vero Fiber and MontanaSky have tied the knot, officially sealing a merger that doesn't just unite two reputable broadband providers but promises to shake up the internet game across the region. Just ask anyone who's tried to stream a movie during peak hours in Flathead Valley. A...

Texas A&M-San Antonio's Research Expansion Momentum

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

New Tools Arm Manufacturers in Additive Arena

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...